# C The Signs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/c-the-signs

- Industry: Healthcare Specialists
- Headquarters: London, UK
- Website: www.cthesigns.co.uk
- Total disclosed funding: $6.7M
- Latest round: Series A (Oct 19, 2021)
- Investors on record: 3

## About

Founded in 2017 and based in London, UK, C The Signs Limited gives GPs the ability to simultaneously check combinations of signs, symptoms, and risk factors. Bhavagaya Bakshi and Miles Payling are the co-founders of the company. In January 2025, C The Signs Limited raised USD 8 million in seed funding led by Khosla Ventures, with participation from MMC Ventures, Ataraxia, and Acequia Capital.


The company's AI-driven cancer detection platform analyses thousands of data points, using a combination of clinical signs, symptoms, risk factors, and other markers, in order to spot which cancer(s) a patient is at risk of and fast-track them to the most appropriate test or referral in less than 30 seconds. The firm uses advanced algorithms combined with optimization and prioritization systems to reflect the natural decision-making process of doctors, translating complex research and guidelines into a simple and intuitive journey for the user.

The company will use the January 2025 funding to expand its early cancer detection operations to the US.

## Funding rounds

- Series A, Oct 19, 2021, $6.7M — MMC Ventures, Acequia Capital, Ataraxia

## Investors

- MMC Ventures (https://capitalatlas.ai/funds/mmc-ventures) — Series A
- Acequia Capital (https://capitalatlas.ai/funds/acequia-capital) — Series A
- Ataraxia (https://capitalatlas.ai/funds/ataraxia) — Series A